Biotech · Private company
Avistone Biotechnology Co., Ltd.
Track this companyFree. Adds Avistone Biotechnology Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials55 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ANS02Phase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ANS014004Phase 1 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ANS03Phase 1 · Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK AlterationClinicalTrials.gov · fetched Nov 12, 2026
- PLB1004Phase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung CancerPHASE1_PHASE2 · RECRUITING · started Jul 10, 2026ClinicalTrials.gov NCT07538804 · fetched Nov 12, 2026
- A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung CancerPHASE1_PHASE2 · NOT_YET_RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07285148 · fetched Nov 12, 2026
- A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Mar 6, 2025ClinicalTrials.gov NCT06716138 · fetched Nov 12, 2026
- A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung CancerPHASE1 · RECRUITING · started Jul 8, 2024ClinicalTrials.gov NCT06046495 · fetched Nov 12, 2026
- A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Jun 24, 2024ClinicalTrials.gov NCT06307795 · fetched Nov 12, 2026